Editorial Methodology & Standards
Last updated: July 2026
In a single line: The Record is an educational resource on peptide verification in Ireland. We do not sell products or give medical advice; where we link to an associated supplier we disclose this as an affiliate link, and our verification criteria do not change as a result. Every claim rests on official sources and analytical literature, with date and review.
Who we are
The Record is written and reviewed by an editorial team with expertise in analytical peptide verification. We publish as an entity rather than under the name of an individual medical authority: our content is educational and verification-focused, not clinical. Where a decision involves personal health, we always refer readers to a licensed healthcare professional.
Why we are independent
We do not sell peptides or any other compound; there is no basket or checkout on this site. Where we link to an associated research supplier, we do so via an affiliate link and may receive a commission at no extra cost to you; we state this clearly. That commercial relationship does not alter our criteria: we continue to flag a weak COA or an opaque supplier by the same standard, because our usefulness depends on honest verification.
What sources we use
We prioritise, in this order, official and verifiable technical sources:
- Regulators: HPRA (Health Products Regulatory Authority, Ireland) and EMA (European Medicines Agency) for marketing authorisation status, quality alerts, and falsification warnings. Where relevant, the WHO for global counterfeit intelligence.
- Analytical standards: the European Pharmacopoeia (Ph.Eur.) for methods such as the bacterial endotoxins test (chapter 2.6.14) and liquid chromatography (chapter 2.2.29).
- Scientific literature: peer-reviewed clinical trials and characterisation studies, cited with author, journal, and year.
We do not cite document numbers we cannot verify, we do not fabricate studies, and we attribute each data point to a named source. If a claim lacks solid backing, we qualify it or do not publish it.
Our verification standard
When explaining how to verify a peptide, we apply a consistent and checkable standard:
How we review and update
- Every guide carries a visible publication date and last-updated date, reflected in the page’s structured data.
- We review content when an official source changes, a regulatory alert is issued, or we identify an error.
- FAQ entries reflect real questions and are kept in sync with their structured data.
Corrections policy
If we identify — or are informed of — an inaccurate figure, we correct it and update the review date. To report an error or suggest a source: [email protected].
First-hand verification
In development
We are developing a framework to document first-hand verifications of real COAs and, where appropriate, independent batch testing to the standard described above. Any proprietary data we publish will be accompanied by the method, the source of the analysis, and its limitations. We do not present as our own any result we have not verified.
What we are NOT
We are not a pharmacy, a clinic, or a substitute for medical judgement. We do not sell, diagnose, or recommend dosages. All information is research-only and educational; any decision concerning your health must be made with a licensed healthcare professional.
Regulatory context: HPRA and EMA (July 2026)
The Health Products Regulatory Authority (HPRA) is Ireland’s national competent authority for medicines. Many research peptides — including GLP-1 analogues — are classified as unauthorised medicinal products when offered for human use without a valid marketing authorisation. The European Medicines Agency (EMA) oversees medicines authorisation across the EU, to which Ireland belongs. The Record reflects the regulatory position as understood at the date stated above; always confirm current status directly with HPRA.